Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatment
- 1 April 1996
- journal article
- clinical trial
- Published by Elsevier BV in Fertility and Sterility
- Vol. 65 (4), 707-710
- https://doi.org/10.1016/s0015-0282(16)58200-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Nafarelin therapy in endometriosis: Long-term effects on bone mineral densityAmerican Journal of Obstetrics and Gynecology, 1994
- Changing concepts of medical treatment of endometriosisActa Obstetricia et Gynecologica Scandinavica, 1993
- Assessment of the risk of post‐menopausal osteoporosis using clinical factorsClinical Endocrinology, 1992
- Gonadotropin-releasing hormone agonists: Strategies formanaging the hypoestrogenic effects of therapyAmerican Journal of Obstetrics and Gynecology, 1992
- Treatment of uterine fibroids: Current findings withgonadotropin-releasing hormone agonistsAmerican Journal of Obstetrics and Gynecology, 1992
- Hormone treatment of endometriosis: The estrogenthreshold hypothesisAmerican Journal of Obstetrics and Gynecology, 1992
- Estrogen and Bone MetabolismObstetrical & Gynecological Survey, 1992
- Critical Years and Stages of Puberty for Spinal and Femoral Bone Mass Accumulation during Adolescence*Journal of Clinical Endocrinology & Metabolism, 1991
- Bone Mineral Density of the Lumbar Spine in Endometriosis Subjects Compared to an Age-Similar Control Population*Journal of Clinical Endocrinology & Metabolism, 1991
- Reduced Bone Mass in Reproductive-Aged Women with Endometriosis*Journal of Clinical Endocrinology & Metabolism, 1989